PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy.
Thorsten DerlinSabine RiethdorfUdo SchumacherMarcel LafosSven PeineCornelia CoithTobias L RossKlaus PantelFrank M BengelPublished in: The Prostate (2023)
This proof-of-principle study suggests that liquid biopsy for CTC PSMA expression is complementary to PET for individual PSMA phenotyping of mCRPC.